NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors : A Retrospective Molecular Tumor Board Analysis
Identifying the mutational landscape of tumors using next-generation sequencing (NGS) has become substantially more common over the past decade, especially in patients with advanced tumors. However, there is still limited real-world evidence for the clinical benefits of NGS-guided precision oncol...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Philipps-Universität Marburg
2024
|
Subjects: | |
Online Access: | PDF Full Text |
Tags: |
No Tags, Be the first to tag this record!
|
Internet
PDF Full TextCall Number: |
urn:nbn:de:hebis:04-es2024-09403 |
---|---|
Publication Date: |
2024-12-02 |
Source: |
Erstveröffentlichung: Gremke, N.; Rodepeter, F.R.; Teply-Szymanski, J.; Griewing, S.; Boekhoff, J.; Stroh, A.; Tarawneh, T.S.; Riera-Knorrenschild, J.; Balser, C.; Hattesohl, A.; et al. NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis. Cancers 2024, 16, 1561. https://doi.org/10.3390/cancers16081561 |
Downloads: |
19 (2025), 4 (2024) |
License: |
https://creativecommons.org/licenses/by/4.0 |
Access URL: |
https://archiv.ub.uni-marburg.de/es/2024/0940 https://doi.org/10.3390/cancers16081561 |